Attached files

file filename
EX-32.1 - EX-32.1 - Sesen Bio, Inc.sesn-03312020x10qex321.htm
EX-31.2 - EX-31.2 - Sesen Bio, Inc.sesn-03312020x10qex312.htm
EX-31.1 - EX-31.1 - Sesen Bio, Inc.sesn-03312020x10qex311.htm
10-Q - 10-Q - Sesen Bio, Inc.sesn-20200331.htm

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Sesen Bio, Inc. (the “Company”) for the fiscal quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:May 11, 2020By:/s/ Monica Forbes 
Name:Monica Forbes
Title:Chief Financial Officer
(Principal Financial Officer)